. home.aspx


Mulesoft: how can API tools speed up drug development?

October 24, 2019 / ALLIE NAWRAT

At its Connect conference in London in early October, MuleSoft brought together its customers and clients across all sectors to discuss how enterprise software, and particularly APIs, can drive efficiencies and contribute to digital transformation. Mulesoft’s David Chao and AstraZeneca’s Satish Maram explain how an API tools can support better connected drug development and help bring products to market quicker. San Franscisco-based MuleSoft provides enterprise software, and particularly application program interface (API) tools through its flagship Anypoint plaform, to various industries ranging from retail to media and financial services. Healthcare is an important industry for MuleSoft – it now has more than 40 healthcare customers globally, including major players in the field, according to head of product marketing David Chao.